Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM    DSM   NL0000009827

ROYAL DSM

(DSM)
  Report
Delayed Quote. Delayed Euronext Amsterdam - 01/17 11:35:20 am
110.5 EUR   +1.05%
01/14ROYAL DSM : DSM - repurchase of shares (6-10 January 2020)
PU
01/07ROYAL DSM : DSM - repurchase of shares (2-3 January 2020)
PU
2019ROYAL DSM : DSM - repurchase of shares (16-20 December 2019)
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Evonik launches auction for acrylic sheet business - sources

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/10/2018 | 10:40am EST
FILE PHOTO: The logo of German specialty chemical company Evonik Industries AG is pictured at their plant in Bitterfeld

FRANKFURT (Reuters) - German chemicals group Evonik has started the auction process for its methacrylates plastics unit, which makes clear acrylic sheets, people close to the matter said.

The company announced plans in March to sell the business as it looks to focus on faster-growing sectors, such as feed additives and rubber silica for tyres.

Evonik and its adviser Barclays have started sending out first information packages to prospective bidders for the unit, which is seen fetching around 2.5-3 billion euros ($2.9-$3.5 bln), the people said.

Potential suitors are to receive detailed information after the summer, and first bids will be due several weeks after that, they added.

Peers such as South Korea's LG Chem and SK Holdings, China's Wanhua Chemical Group and Saudi Arabia's Sabic are being contacted about their potential interest, as well as U.S. chemicals firms LyondellBasell and DowDuPont, they added.

Separately, private equity investors with an interest in chemicals assets such as Advent, Carlyle, Blackstone and Apollo are seen as likely to participate in the auction, they added.

Evonik said its efforts to divest the business were on track but declined to provide further details. The potential suitors declined to comment or were not immediately available.

The business up for sale posted 2017 earnings before interest, tax, depreciation and amortisation of less than 400 million euros on 1.8 billion euros of sales from clear acrylic sheets and methacrylate chemicals, the people said.

"2017 was the top of the cycle and Evonik benefited from capacity outages at peers," a person close to the matter said, adding overhead costs also needed to be taken into account when looking at the business on a standalone basis, while allowing for some synergies.

The people said bidders would likely offer 2 to 2.5 billion euros for the asset, including debt, or 7 to 8 times the unit's expected adjusted core earnings, while the seller was hoping to bag up to 3.5 billion.

Shares in Evonik, which is controlled by a state-backed foundation, lags peers such as BASF, Lanxess and DSM as a multiple of expected core earnings.

Polymethyl methacrylate (PMMA) is used in the construction, automotive and electronics industries and known by brand names such as Plexiglas.

($1 = 0.8538 euros)

(Editing by Maria Sheahan and Mark Potter)

By Arno Schuetze and Matthias Inverardi

Stocks mentioned in the article
ChangeLast1st jan.
BASF SE 0.20% 64.52 Delayed Quote.-4.20%
EVONIK INDUSTRIES AG 0.87% 25.42 Delayed Quote.-6.58%
LANXESS 0.14% 56.38 Delayed Quote.-5.75%
LG CHEM LTD End-of-day quote.
LYONDELLBASELL INDUSTRIES N.V. 0.54% 92 Delayed Quote.-2.62%
ROYAL DSM 1.05% 110.5 Delayed Quote.-4.82%
SK HOLDINGS CO LTD End-of-day quote.
WANHUA CHEMICAL GROUP CO., LTD. -0.35% 53.92 End-of-day quote.-3.67%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ROYAL DSM
01/14ROYAL DSM : DSM - repurchase of shares (6-10 January 2020)
PU
01/07ROYAL DSM : DSM - repurchase of shares (2-3 January 2020)
PU
2019ROYAL DSM : DSM - repurchase of shares (16-20 December 2019)
PU
2019ROYAL DSM : DSM - repurchase of shares (9-13 December 2019)
PU
2019ROYAL DSM : DSM - repurchase of shares (2-6 December 2019)
PU
2019ROYAL DSM : Update on DSM Supervisory Board composition
PU
2019ROYAL DSM : DSM - repurchase of shares (25-29 November 2019)
PU
2019ROYAL DSM : announces CEO succession
PU
2019ROYAL DSM : DSM introduces new MaxaGourmet™ clean label taste solutions fo..
PU
2019ROYAL DSM : DSM - repurchase of shares (18-22 November 2019)
PU
More news
Financials (EUR)
Sales 2019 9 112 M
EBIT 2019 1 102 M
Net income 2019 824 M
Debt 2019 1 337 M
Yield 2019 2,19%
P/E ratio 2019 23,2x
P/E ratio 2020 21,3x
EV / Sales2019 2,18x
EV / Sales2020 2,08x
Capitalization 18 526 M
Chart ROYAL DSM
Duration : Period :
Royal DSM Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 116,65  €
Last Close Price 110,50  €
Spread / Highest target 33,0%
Spread / Average Target 5,56%
Spread / Lowest Target -33,9%
EPS Revisions
Managers
NameTitle
Feike Sijbesma Chairman-Management Board & CEO
Robert John Routs Chairman-Supervisory Board
Géraldine Matchett Chief Financial Officer
Pauline F. M. van der Meer Mohr Deputy Chairman
Victoria Franchetti Haynes Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM-4.82%20 551
BASF SE-4.20%65 735
SHIN-ETSU CHEMICAL CO., LTD.6.18%47 406
DUPONT DE NEMOURS, INC.-4.11%45 604
GROUPE BRUXELLES LAMBERT2.32%16 645
ASAHI KASEI CORPORATION-1.41%14 830